The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers. [electronic resource]
Producer: 20180406Description: 44605-44624 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents, Immunological -- pharmacology
- Cell Cycle -- drug effects
- Cell Survival
- Disease Models, Animal
- Endocytosis
- Gene Expression
- Humans
- Immunoconjugates -- pharmacology
- Leukemia -- drug therapy
- Mannose-Binding Lectins -- antagonists & inhibitors
- Membrane Glycoproteins -- antagonists & inhibitors
- Mice
- Molecular Targeted Therapy
- Receptors, Cell Surface -- antagonists & inhibitors
- Receptors, Mitogen -- antagonists & inhibitors
- Sarcoma -- drug therapy
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.